JENNIFER DAY: Open Payments
NPI 1417499161 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 72 payments from 14 companies in 2025. Trend: 2023 $146 · 2024 $964 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $324 |
| AstraZeneca Pharmaceuticals LP | 4 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $162 |
| PFIZER INC. | 10 | $147 |
| Novo Nordisk Inc | 6 | $93 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Phathom Pharmaceuticals, Inc. | 5 | $65 |
| Dynavax Technologies Corporation | 3 | $63 |
| Amgen Inc. | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: CAPLYTA, VRAYLAR, UBRELVY, FARXIGA, TRELEGY ELLIPTA, VOQUEZNA, Heplisav-B, Ozempic.
Industry payments across KY — which companies pay providers there.
